Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 5/20 | 0.58 |
| ▸ | F3 | P13726 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | PPARA | Q07869 | 4/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | PPARD | Q03181 | 3/20 | 0.58 |
| ▸ | BLM | P54132 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19693072 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL12612200 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL12612202 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL23698128 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL23698126 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL23698096 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL23698229 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL23698232 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL2011808 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL28102296 | 1.00 | F7 (0.58) | F7F3ALDH1A1CYP19A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110573150-B | Composition for inhibiting proliferation of bacteria having menaquinone synthesis pathway via furalosine or furalosine derivative | 内斯托尔株式会社 | 2024-02-27 | — | — | CN | claimed |
| CN-117243221-A | Fall-back fall webworm disorientation dispersing agent | 中捷四方生物科技股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-111278984-B | Homo-polymer of fatty acid hydroxide and method for producing the same | 国立大学法人京都大学 | 2023-09-29 | — | — | CN | claimed |
| CN-116440112-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2023-07-18 | — | — | CN | claimed |
| US-10952983-B2 | Metabolism-improving agent comprising rare fatty acid | KYOTO UNIVERSITY (JP) | 2021-03-23 | — | — | US | claimed |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-03-11 | — | — | US | claimed |
| CN-111893142-A | Method for producing rare fatty acid using novel enzyme and novel rare fatty acid | 国立大学法人京都大学 | 2020-11-06 | — | — | CN | claimed |
| CN-107075502-B | Method for producing rare fatty acid using novel enzyme and novel rare fatty acid | 国立大学法人京都大学 | 2020-07-10 | — | — | CN | claimed |
| CN-111278984-A | Homopolymers of hydroxylated fatty acids and process for producing the same | 国立大学法人京都大学 | 2020-06-12 | — | — | CN | claimed |
| CN-110573150-A | Composition for inhibiting proliferation of bacteria having menaquinone synthesis pathway via futalosine or futalosine derivative | 日东药品工业株式会社 | 2019-12-13 | — | — | CN | claimed |
| CN-106456586-A | Metabolism-improving agent comprising rare fatty acid | 国立大学法人京都大学 | 2017-02-22 | — | — | CN | claimed |
| CN-106163511-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2016-11-23 | — | — | CN | claimed |
| CN-104902887-A | Metabolism-improving agent comprising rare fatty acid | UNIV KYOTO | 2015-09-09 | — | — | CN | claimed |
| US-20150125911-A1 | METHOD FOR PRODUCING OXO FATTY ACID AND RARE FATTY ACID | NOSTER INC. (JP) | 2015-05-07 | — | — | US | claimed |
| CN-104602512-A | Improving fatty acid profile of camelina sativa oil | LINNAEUS PLANT SCIENCES INC | 2015-05-06 | — | — | CN | claimed |
| CN-1257541-A | Plant fatty acid epoxidase and its use | COMMW SCIENT IND RES ORG (AU) | 2000-06-21 | — | — | CN | claimed |
| CN-119562806-A | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | 阿卡格拉医药公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-117784522-A | Curable composition and method for producing same | 株式会社钟化 | 2024-03-29 | — | — | CN | disclosed |
| EP-1009220-A1 | PRODUCTION OF HYDROXYLATED FATTY ACIDS IN GENETICALLY MODIFIED PLANTS | CARNEGIE INSTITUTION OF WASHINGTON (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1997030582-A1 | PRODUCTION OF HYDROXYLATED FATTY ACIDS IN GENETICALLY MODIFIED PLANTS | CARNEGIE INSTITUTION OF WASHINGTON (US) | 1997-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10952983-B2 | Metabolism-improving agent comprising rare fatty acid | FASN, ELOVL1, FADS1 | F7 2524/4885F3 2403/4885ALDH1A1 700/4885 |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | F7 1301/4885F3 1074/4885ALDH1A1 846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.